Collectively, these studies suggest that obesity-associated variants of FTO regulate the expression of IRX3 and IRX5 in the hypothalamus and adipose tissue contributing to metabolic changes. Here, IRX3 is linked to obesity due to melanocortin 4 receptor deficiency.